Topics

Medical 21 developing artificial medical graft for use in bypass surgery

07:54 EDT 2 May 2019 | Proactive Investors

Medical 21 CEO Dr. Manny Villafana joined Proactive's Christine Corrado at the 2019 Think Equity conference in New York to talk about their medical company that is developing an artificial graft for patients undergoing bypass surgery. If successful, this would eliminate the need to harvest vessels from a patients body. 

Original Article: Medical 21 developing artificial medical graft for use in bypass surgery

NEXT ARTICLE

More From BioPortfolio on "Medical 21 developing artificial medical graft for use in bypass surgery"

Quick Search

Relevant Topic

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...